Sixfold Bioscience, a biotechnology company focused on the development of drug delivery systems for gene therapeutics, has been awarded a third grant through the ‘Analysis for Innovators’ (A4I) programme co-funded by the UK’s innovation agency — Innovate UK. The project will expand the capabilities of Sixfold’s proprietary delivery systems.
Sixfold Bioscience awarded two Innovate UK grants to advance the development of their cell and gene therapeutic delivery system.
Jellyfish collagen set to revolutionise in vitro cell culture and tissue engineering.
A4I gives UK businesses access to cutting-edge R&D, expertise and techniques. Five new partners have joined the Analysis for Innovators Programme.
Lien Ngo, Innovate UK's Innovation Lead for Advanced Materials, on the benefits of A4i and taking a problem focused approach.
Details of the A4I Round 5 competition have been published on the .gov website. There will be two competition streams:
- Stream 1 - Projects up to 3 months - that can attract de minimis (100%) funding
- Stream 2 - Projects up to 12 months - that will be grant funded